Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists

3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists

US Patent 6387885 · Granted May 14, 2002

Estimated economic value: $75,315,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Synthesis of novel ketone body analogs for use as a nutritional supplement2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Anti-c-Met antibody drug conjugates2023
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Pyridine CDK9 kinase inhibitors2017
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments contai2016
7-substituted indole Mcl-1 inhibitors2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2016